Brian Farley / President and CEO, Executive Chairman of the Board
bfarley@entellusmedical.com
Brian E. Farley is President and CEO of Entellus Medical, Inc. He was the President and CEO of VNUS® Medical Technologies, Inc. beginning in 1995 as the first employee and ending in 2009 when VNUS was acquired by Covidien for over $500 million. Mr. Farley previously held various management and executive positions in research and development, clinical research and business development at Guidant Corporation, and in the medical device division of Eli Lilly & Co.
Josh Baltzell / Split Rock Partners
www.splitrock.com
Josh Baltzell joined Split Rock Partners at the firm's inception as a Principal with the healthcare investment team. He has been involved in virtually all aspects of medical devices companies, ranging from product development to the acquisition and sale of mature organizations. Previously, Mr. Baltzell worked at Piper Jaffray in their healthcare investment banking group and has also held various marketing and business development positions at Boston Scientific’s cardiology division.
Dave Milne / SV Life Sciences
www.svlsa.com
David Milne joined SVLS in 2005. David has over 21 years of operating experience in leading therapeutic and diagnostic medical technology corporations. David currently sits on the board of directors for, AqueSys, CardioMind, EBR, Entellus, Novalign, ReShape, Sadra, Spinal Kinetics, and TransEnterix. He is also on the boards of Mindframe and Altura Interventional which reside in the incubator medical technology incubator Intersect Partners. From 1999, until joining SVLS, he held the position of Vice President of Corporate Business Development at Boston Scientific Corporation and was responsible for over 50 transactions totaling nearly $2 billion in acquisitions, equity investments and development partnerships. Prior responsibilities included executive level positions in marketing, Corporate Planning, and Sales with Boston Scientific, Becton Dickinson and Parker Laboratories. David holds an MBA from New York University and a BS in Biochemistry from Rutgers University.
Thomas Ressemann / Chief Business Development Officer and Co-founder
tressemann@entellusmedical.com
Thomas Ressemann is the Chief Business Development Officer and Former President and CEO of Entellus Medical, Inc. He brings 21 years of experience to Entellus Medical, including medical device engineering, product creation, operations, fundraising and sales/marketing. Mr. Ressemann previously worked at Boston Scientific/SCIMED, TeraMed and Velocimed.
Guido Neels / Essex Woodlands
www.essexwoodlands.com
Mr. Guido Neels is a partner at Essex Woodlands. Mr. Neels served as Chief Operating Officer of Guidant Corporation. At Guidant, he was Group Chairman, Office of the President. At Eli Lilly and Raychem, he held various general management, sales and marketing, information technology, finance and manufacturing positions. He holds a MBA degree from Stanford and a Business Engineering degree from University of Leuven in Belgium.